TAM Receptors and Flavivirus Infection
TAM 受体和黄病毒感染
基本信息
- 批准号:8534705
- 负责人:
- 金额:$ 37.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-21 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteArbovirusesAttenuatedBindingBiochemicalBiologicalCell Surface ReceptorsCell surfaceCellsChemosensitizationDendritic CellsDengue VirusDiseaseEncephalitisEventFamilyFlavivirusFlavivirus InfectionsGenesGeneticHistologicHumanImageImmune responseImmune systemIn VitroInfectionInflammatory ResponseInterferon ReceptorInterferon Type IInterferonsLabelLigand BindingLigandsLinkMeasuresMediatingMemory B-LymphocyteMethodsMolecularMonoclonal AntibodiesMusMutant Strains MiceMutationNeuraxisNeuronsPathogenesisPathway interactionsPhosphatidylserinesPhospholipidsPhysiologicalPlayProductionProtein SProtein Tyrosine KinasePublic HealthReceptor ActivationReceptor Protein-Tyrosine KinasesRegulationRelative (related person)ResistanceRoleSentinelSignal TransductionSurfaceT cell responseTimeTissuesViralVirionVirulentVirusVirus DiseasesVirus ReplicationWest Nile viruschemokinecytokinedesignin vivoinhibitor/antagonistmacrophagemembernervous system developmentnovelparticlepathogenreceptorresearch studyresponsesubcutaneoustype I interferon receptorvirus pathogenesis
项目摘要
DESCRIPTION (provided by applicant): The receptor tyrosine kinases (RTKs) of the TAM family - Tyro3, Axl, and Mer - are exploited by flaviviruses, such as West Nile Virus and Dengue Virus, to infect their target cells. The experiments of this proposal are designed to elucidate how
TAM potentiation of infection is achieved. TAM RTKs are expressed on the surface of many cells, including dendritic cells and macrophages of the immune system, and neurons of the central nervous system. The ligands that bind to and activate the TAMs - Gas6 and Protein S (ProS) - have the ability to attach both to the phospholipid phosphatidylserine, expressed on the surface of flavivirus particles, and also to their cognate TAM receptor. In this way, the TAM ligands serve as a 'bridge' that links flaviviruses to the surface of cells that they will infect. t the same time, TAM receptor activation by Gas6 or ProS results in the inhibition of type I interferon (IFN) signaling, to which flaviviruses and many other viruses are sensitive. In Aim 1, genetic, biochemical, and cell biological methods will be used to dissect the mechanisms through which TAM receptors facilitate flavivirus entry into human cells in vitro. In Aim 2, these same methods will be used in experiments in dendritic cells and macrophages prepared from mice that carry targeted mutations in the Axl and Mer genes, and in CNS neurons prepared Tyro3 mutant mice, to define the TAM receptors and ligands that promote infection in different cellular settings, and to determine the extent to which TAM facilitation of flavivirus infection is dependent on the inhibition of type I IFN signaling. In Aim 3, mice that carry mutations in the Tyro3, Axl, Mer, Gas6, and ProS genes will be used to assess the cellular and immunological consequences of specific deficits in TAM signaling for infection by West Nile Virus in vivo. Together, these experiments will delineate the molecular, cellular, and physiological features of a heretofore unknown pathway of flavivirus infection.
描述(由申请人提供):TAM家族的受体酪氨酸激酶(RTK) - Tyro3,Axl和Mer-由黄病毒(例如西尼罗河病毒和登革热病毒)剥削,以感染其靶细胞。该提案的实验旨在阐明如何
实现了感染的TAM增强。 TAM RTK在许多细胞的表面表达,包括树突状细胞和免疫系统的巨噬细胞以及中枢神经系统的神经元。结合并激活TAMS -GAS6和蛋白S(ProS)的配体具有连接到磷脂磷脂酰丝氨酸上的能力,该甲氧氨基在黄病毒颗粒表面表达,也表达了其同源性TAM受体。这样,TAM配体充当了将黄病毒连接到会感染细胞表面的“桥”。 t同一时间,GAS6或PROS激活TAM受体会导致I型干扰素(IFN)信号传导的抑制,而黄病毒和许多其他病毒对此是敏感的。在AIM 1中,将使用遗传,生化和细胞生物学方法来剖析TAM受体在体外促进黄病毒进入人类细胞的机制。 In Aim 2, these same methods will be used in experiments in dendritic cells and macrophages prepared from mice that carry targeted mutations in the Axl and Mer genes, and in CNS neurons prepared Tyro3 mutant mice, to define the TAM receptors and ligands that promote infection in different cellular settings, and to determine the extent to which TAM facilitation of flavivirus infection is dependent on the inhibition of type I IFN信号。在AIM 3中,将使用TYRO3,AXL,MER,GAS6和PROS基因中携带突变的小鼠评估TAM信号在Vivo In Vivo中感染TAM信号传导中特定缺陷的细胞和免疫学后果。这些实验将共同描绘出迄今未知的Flavivivirus感染途径的分子,细胞和生理特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Greg E Lemke其他文献
Greg E Lemke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Greg E Lemke', 18)}}的其他基金
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
8856378 - 财政年份:2013
- 资助金额:
$ 37.51万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
9103238 - 财政年份:2013
- 资助金额:
$ 37.51万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
8615692 - 财政年份:2013
- 资助金额:
$ 37.51万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
9278310 - 财政年份:2013
- 资助金额:
$ 37.51万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
8732718 - 财政年份:2013
- 资助金额:
$ 37.51万 - 项目类别:
相似海外基金
Transfusion-related immunomodulation influences infectious disease outcomes
输血相关的免疫调节影响传染病的结果
- 批准号:
10439852 - 财政年份:2020
- 资助金额:
$ 37.51万 - 项目类别:
Transfusion-related immunomodulation influences infectious disease outcomes
输血相关的免疫调节影响传染病的结果
- 批准号:
10249277 - 财政年份:2020
- 资助金额:
$ 37.51万 - 项目类别:
Transfusion-related immunomodulation influences infectious disease outcomes
输血相关的免疫调节影响传染病的结果
- 批准号:
10634538 - 财政年份:2020
- 资助金额:
$ 37.51万 - 项目类别:
Transfusion-related immunomodulation influences infectious disease outcomes
输血相关的免疫调节影响传染病的结果
- 批准号:
10034518 - 财政年份:2020
- 资助金额:
$ 37.51万 - 项目类别: